TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T15707 AS T21915. XX ID T15707 XX DT 30.07.2008 (created); ane. DT 12.06.2015 (updated); hna. CO Copyright (C), QIAGEN. XX FA NF-kappaB2-p52 XX SY Lyt-10; NF-kappaB2; NF-kappaB2 (p52); NFKB2-p50B; p52. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX CL C0020; Rel. XX IN T08711 RelA-p65; human, Homo sapiens. XX MX M00774 V$NFKB_Q6_01. XX BS R30673. BS R61153. BS R55830. BS R30672. BS R29952. BS R66266. BS R60487. BS R68249. BS R68253. BS R40953. BS R66698. BS R66699. BS R66701. BS R63241. BS R26907. BS R64783. XX DR TRANSPATH: MO000131473. XX RN [1]; RE0053976. RX PUBMED: 15708970. RA Hauer J., Puschner S., Ramakrishnan P., Simon U., Bongers M., Federle C., Engelmann H. RT TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. RL Proc. Natl. Acad. Sci. USA 102:2874-2879 (2005). RN [2]; RE0069790. RX PUBMED: 15660126. RA Sitcheran R., Gupta P., Fisher P. B., Baldwin A. S. RT Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression. RL EMBO J. 24:510-520 (2005). RN [3]; RE0070954. RX PUBMED: 20460684. RA Tando T., Ishizaka A., Watanabe H., Ito T., Iida S., Haraguchi T., Mizutani T., Izumi T., Isobe T., Akiyama T., Inoue J., Iba H. RT Requiem protein links RelB/p52 and the Brm-type SWI/SNF complex in a noncanonical NF-kappaB pathway. RL J. Biol. Chem. 285:21951-21960 (2010). XX //